A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug...

Another and promising class of synthetic mixes has the noteworthy potential for treating Zika disease and respiratory syncytial infection, or RSV, according to another examination by University of Alberta scientists. The accompanying stage is to develop a medication.
"This is both a wonderful scientific discovery and something that can possibly emphatically influence worldwide wellbeing as well as the economy of Canada," said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant. The compound is alike isatisine A which is an antiviral compound usually found in traditional Chinese herbal medicine.
Hobman is a professor of cell biology and a specialist in the Zika virus, a pathogen that can cause a severe pre-birth defect in pregnant ladies that has been on the public radar since a major outbreak in May 2015. Marchant is a professor of medical microbiology and a specialist in RSV, which represents the greatest hazard to babies, the elderly, and the immunocompromised. The infection can be responsible for more than 30% of all hospitalized respiratory cases in any given year.

The following stage of medical improvement is now in progress. "What we intend to do is further refine this compound, to keep the components that make it therapeutically dynamic and work in the auxiliary parts that make it feasible for patients to expend in medicate shape," clarified West. "We are moving toward that point."
For more details go through the link: https://bacteriology.infectiousconferences.com/abstract-submission.php

Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m
Read more

How one bacterium inhibits predators with poison:

Image
How one bacterium inhibits predators with poison: Microbiologists in South Korea report that the bacterium Chromobacterium piscinae produce cyanide when under attack from Bdellovibrio bacteriovorus HD100, a microbial predator found in streams and soils that ingests its prey from the top to bottom. Scientists found that the prey delivered levels of cyanide sufficiently high to hinder, but not kill, the B. bacteriovorus HD100. Examinations demonstrated that C. piscinae secrete the defensive cyanide in a nutrient-rich broth. In a medium without supplements, it didn't secrete the cyanide and was consumed. The scientists suspect that the microorganisms likely uses some ingredients in the broth to secrete the cyanide. That perception suggests that microscopic organisms' defenses may depend on location-- and, more generally, that microorganism may harbor defensive components that are activated in a suitable environment, but not in others. To test whether cyanide alone was d
Read more